I am a board-certified hematologic oncologist who specializes in caring for people with leukemias and myelodysplastic syndrome. I also conduct leukemia research as part of the Ross Levine laboratory. My special interests in bone marrow failure and myeloid neoplasms aim to translate epigenetic insights into novel treatment approaches.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more